Hudson Bay Capital Management LP Has $12.97 Million Stock Position in The Clorox Company (NYSE:CLX)

Hudson Bay Capital Management LP boosted its stake in shares of The Clorox Company (NYSE:CLX) by 35.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 79,857 shares of the company’s stock after buying an additional 20,766 shares during the quarter. Hudson Bay Capital Management LP’s holdings in Clorox were worth $12,970,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of CLX. Norges Bank acquired a new position in Clorox during the 4th quarter valued at $259,041,000. FMR LLC lifted its holdings in shares of Clorox by 75.4% during the 4th quarter. FMR LLC now owns 1,361,758 shares of the company’s stock worth $221,163,000 after acquiring an additional 585,526 shares during the period. Marshall Wace LLP lifted its holdings in shares of Clorox by 549.8% during the 4th quarter. Marshall Wace LLP now owns 542,726 shares of the company’s stock worth $88,144,000 after acquiring an additional 459,203 shares during the period. ExodusPoint Capital Management LP lifted its holdings in shares of Clorox by 187.9% during the 4th quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after acquiring an additional 456,114 shares during the period. Finally, Balyasny Asset Management L.P. lifted its holdings in shares of Clorox by 28.7% during the 4th quarter. Balyasny Asset Management L.P. now owns 1,421,909 shares of the company’s stock worth $230,932,000 after acquiring an additional 316,688 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Pierre R. Breber bought 4,000 shares of the company’s stock in a transaction on Wednesday, May 7th. The stock was bought at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director now owns 4,000 shares in the company, valued at approximately $546,280. The trade was a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.57% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CLX. Barclays reduced their price objective on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a report on Wednesday, May 7th. JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating for the company in a report on Tuesday, May 6th. UBS Group reduced their price objective on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Wells Fargo & Company reduced their price objective on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Finally, Morgan Stanley reduced their price objective on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Clorox has a consensus rating of “Hold” and an average target price of $151.23.

Clorox Trading Down 2.2%

Shares of NYSE CLX opened at $134.79 on Monday. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a market cap of $16.60 billion, a PE ratio of 36.83, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a 50-day moving average of $142.37 and a two-hundred day moving average of $154.03.

Clorox (NYSE:CLX) last announced its earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the firm posted $1.71 earnings per share. The company’s revenue was down 8.0% on a year-over-year basis. As a group, equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.62%. The ex-dividend date of this dividend was Wednesday, April 23rd. Clorox’s dividend payout ratio is presently 87.61%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.